Artificial Intelligence​

Stratipath’s novel solutions are driven by a rigorous scientific development process based on state-of-the-art machine and deep learning methods.

We use real-world datasets comprising of histopathology images, clinical labels and patient outcomes, with all models validated using fully independent data to ensure model generalisability, automated pre-processing and quality control measures.

Unique data

Stratipath has unique, multi-source, large and growing population representative cohorts with histopathology images and associated clinical outcome data, allowing the capture of natural variability across all cancer patients.

Clinical evidence

All solutions undergo rigorous retrospective and prospective internal and external validation in close collaboration with clinical stakeholders and academic experts.

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more